Sharon E. Frey

St. Louis VA Medical Center — United States

Medicine · Health Sciences

51h-index7.4kcitations179works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(40), Poxvirus research and outbreaks(37), Immunotherapy and Immune Responses(33), SARS-CoV-2 and COVID-19 Research(31), Respiratory viral infections research(27)

Publications172 total

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination
Vaccine·2025Open Access
Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network
Clinical Infectious Diseases·2025· 2 cited
Vaccine and Treatment Evaluation Units: A Historical Perspective
Clinical Infectious Diseases·2025· 1 cited
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units
Clinical Infectious Diseases·2025Open Access
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines
Vaccines·2025· 1 citedOpen Access
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age
Vaccine·2025· 2 cited
579. Safety and Immunogenicity of Mpox Vaccination in Adolescents
Open Forum Infectious Diseases·2025· 2 citedOpen Access
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Nature Communications·2025· 8 citedOpen Access
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®
Vaccine·2025· 2 citedOpen Access
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
Vaccine·2025· 2 citedOpen Access
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity
Vaccines·2024· 1 citedOpen Access
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Clinical Infectious Diseases·2024· 3 citedOpen Access
Investigating the Potential Neuroprotective Therapeutic Effects of Mitoapocynin on Epilepsy Using a Rat Model
2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
Clinical Infectious Diseases·2024· 8 citedOpen Access
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Nature Medicine·2023· 53 citedOpen Access
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
The Journal of Infectious Diseases·2023· 3 citedOpen Access
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial
The Journal of Infectious Diseases·2023· 7 citedOpen Access
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
2023Open Access
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial
2023· 5 citedOpen Access
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial
Science Translational Medicine·2023· 45 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Robert B. Belshe(18), Frances K. Newman(9), Heather Hill(8), David C. Montefiori(7), Mark J. Mulligan(7), Lawrence Corey(7), Paul Spearman(7), Mark Wolff(6), Robert L. Atmar(6), Lisa A. Jackson(6), Kathryn M. Edwards(6), Irene Graham(6), Michael C. Keefer(6), M. Juliana McElrath(6), Jeffrey S. Kennedy(5), Paul A. Goepfert(5), Georgia D. Tomaras(5), Lindsey R. Baden(5), Michael Houghton(4), Francis A. Ennis(4)